Glyfosfin

甘磷酰芥

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGlyfosfin
Drug Alias NameGlyciphosphoramide
ClassificationSmall molecules
Mechanisms of ActionDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsUterine Cervical NeoplasmsSmall Cell Lung CarcinomaBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsSmall Cell Lung CarcinomaBreast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A